Target intelligence / Profile preview

Branched-chain amino acid metabolism (null)

Target
null
Molecular classification
Other
01

Overview

Branched-chain amino acid metabolism refers to the collective biochemical pathways responsible for the breakdown and utilization of the essential branched-chain amino acids—leucine, isoleucine, and valine. These pathways are not a single molecule or receptor but involve multiple enzymes including branched-chain aminotransferases (BCATs) and the branched-chain α-ketoacid dehydrogenase complex (BCKDH). The process primarily occurs in skeletal muscle but also involves adipose tissue, liver, kidney, pancreas, and heart. Proper regulation of these pathways is crucial for protein synthesis; energy production; maintenance of glucose homeostasis; immune function; neurotransmitter balance; and cellular growth via mTOR signaling. Dysregulation or chronic elevation of BCAAs or their metabolites can contribute to insulin resistance, obesity-related complications, certain cancers where enzymes like BCAT1 serve as prognostic markers or therapeutic targets. Note: "Branched-chain amino acid metabolism" describes a pathway/system rather than a discrete molecular target. It does not refer to a specific receptor/protein/enzyme but rather encompasses several molecules involved in this metabolic process. Therefore: - is_target: false — it is not itself considered a direct therapeutic target. - is_incorrect: true — this entry does not correspond to an individual molecule/receptor/target suitable for drug targeting without further specification. For structured data on actual drug targets within this pathway—such as "branched-chain aminotransferase 1" (BCAT1) or "branched-chain α-ketoacid dehydrogenase complex"—those should be specified individually.

Other names
BCAA metabolismbranched-chain amino acid catabolismBCAA catabolism
02

Mechanism of action

null

03

Biological functions

Protein synthesisEnergy productionRegulation of glucose and lipid metabolismmTOR signaling regulationImmune cell function (lymphocyte proliferation, dendritic cell maturation)Neurotransmitter synthesis
04

Disease associations

Metabolic disease (obesity, type 2 diabetes, metabolic-associated fatty liver disease)CancerInsulin resistanceMuscle wasting disorders
05

Safety considerations

Chronic elevation of BCAAs is associated with increased risk for metabolic diseases such as obesity and type 2 diabetes
06

Biomarkers

BCAT1BCKDH

Beyond the preview

Go deeper on Branched-chain amino acid metabolism (null).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Branched-chain amino acid metabolism (null).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call